The DOI matches its Crossref record; 66 of the 69 references it cites were found in a registry or an index; 25 of the 44 sources its claims cite were checked for support.
Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
Open accessAbstract
Globally, excess deaths during 2020–21 outnumbered documented COVID-19 deaths by 9.5 million, primarily driven by deaths in low- and middle-income countries (LMICs) with limited vital surveillance. Here we unravel the contributions of probable COVID-19 deaths from other changes in mortality related to pandemic control measures using medically-certified death registrations from Madurai, India—an urban center with well-functioning vital surveillance. Between March, 2020 and July, 2021, all-cause deaths in Madurai exceeded expected levels by 30% (95% confidence interval: 27–33%). Although driven by deaths attributed to cardiovascular or cerebrovascular conditions, diabetes, senility, and other uncategorized causes, increases in these attributions were restricted to medically-unsupervised deaths, and aligned with surges in confirmed or attributed COVID-19 mortality, likely reflecting mortality among unconfirmed COVID-19 cases. Implementation of lockdown measures was associated with a 7% (0–13%) reduction in all-cause mortality, driven by reductions in deaths attributed to injuries, infectious diseases and maternal conditions, and cirrhosis and other liver conditions, respectively, but offset by a doubling in cancer deaths. Our findings help to account for gaps between documented COVID-19 mortality and excess all-cause mortality during the pandemic in an LMIC setting.
Overview
CoChat Summary
TL;DR
In Madurai, India, all-cause deaths from March 2020 to July 2021 exceeded expected levels by 30% (95% CI 27–33%), with excess concentrated in older adults and largely attributed to cardiovascular/cerebrovascular conditions, diabetes, senility, and uncategorized causes, especially in community deaths. Lockdown implementation was associated with a 7% (0–13%) reduction in all-cause mortality, but cause-specific shifts included fewer injury, infectious/maternal, and liver deaths and a doubling of cancer deaths early in lockdown.
Key findings
- Total pandemic period: 15,377 expected deaths vs. 20,004 observed, giving 4,627 excess deaths and an excess mortality ratio of 1.30 (1.27–1.33). Mortality was 49% (43–56%) higher during the first wave and 85% (78–93%) higher during the second wave.
- Cardiovascular/cerebrovascular conditions accounted for 61.5% (2,864/4,627) of all excess mortality; diabetes deaths were 23% higher (IRR 1.23 [1.06–1.43]), senility deaths 84% higher (61–112%), and other uncategorized deaths 41% higher (33–50%).
- Deaths attributed to infectious/maternal conditions fell 50% (49–59% lower), injuries fell 18% (7–28% lower), and chronic liver disease fell 60% (IRR 0.40 [0.32–0.51]) over the total period. Cancer deaths rose 109% (63–169%) during early lockdown, remained 20% (0–45%) above expected through the first wave, then fell 43% (23–57% lower) during the second wave.
- Each one-standard-deviation increase in ward-level deprivation was associated with 5% (1–9%) higher overall excess all-cause mortality and 11% (5–17%) higher healthcare-setting deaths; during the second wave, associations were 19% (10–28%) overall and 50% (35–65%) in healthcare settings.
Methods
- Retrospective analysis of Civil Registration System and Medically-Certified Cause of Death records for all deaths in Madurai Corporation, Tamil Nadu, India, comparing 2020–21 pandemic periods to 2018–19 baseline mortality. Periods included total pandemic (1 March 2020–31 July 2021), early lockdown (24 March–31 May 2020), first wave (1 June–30 September 2020), second wave (16 March–15 July 2021), and a control period (1–23 March 2020).
- Poisson regression models estimated expected deaths and incidence rate ratios, with population offsets for age- and sex-specific population changes; excess deaths were quantified by subtracting projected mortality from observed mortality. Cause-specific analyses were stratified by healthcare vs. community setting, and two-week moving averages of excess deaths were correlated with deaths attributed to COVID-19 and deaths among confirmed SARS-CoV-2 cases.
- Ward-level socioeconomic analyses used a deprivation index from the first principal component of 2011 Census of India indicators, with regression models repeated across 10,000 draws from the excess mortality distribution.
Limitations
- The paper states that cause-of-death determinations in MCCD data are imperfect, so findings represent changes in assigned causes over time rather than the true distribution of causes; many deaths were unassigned at the height of the second wave, rare causes and small strata had unstable counts, and no updated Census data were available after 2011. Ward-level analyses may mask socioeconomic variation, lack of reliable up-to-date population and migration estimates precluded per-capita mortality estimation, and Madurai is one city whose findings may not generalize uniformly, especially to rural contexts.
- Evident from the text: cause-of-death misclassification and differential attribution could affect cause-specific patterns; reliance on 2018–19 baseline mortality and projected population sizes introduces uncertainty; and the observational design cannot establish causality for associations with lockdown measures or deprivation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Observed and expected deaths. We plot observed and expected deaths as well as total excess deaths estimated to have occurred during the analysis period of March 2020 to July 2021, including for all settings (A, B), deaths in healthcare facilities (C, D), and deaths in community settings (E, F). Panels illustrating observed and expected deaths (A, C, E) present observed deaths as red points with accompanying red lines indicating 14-day moving average values. Expected deaths (sampled via Poisson distributions fitted with 2-week moving-average mortality rates from 2018–19, accounting for changes in population size [Table S19]) are presented as black lines (median estimates) along with 95% uncertainty intervals (gray shading). Panels illustrating total excess deaths (difference of observed deaths minus expected deaths; B, D, F) present 14-day moving average values as black lines (median estimates) along with 95% uncertainty intervals (gray shading). Accompanying red lines illustrate 2-week moving averages of total deaths attributed to COVID-19 in the medically certified cause of death data; blue lines indicate 2-week moving averages of deaths among individuals with confirmed SARS-CoV-2 infection occurring within <30 days of the positive test date. We plot corresponding age- and sex-stratified comparisons of observed and expected deaths in Fig. S1.](/paper-figures/2d41b25762d446098689537db8febd4b/attributed-causes-of-excess-mortality-during-the-covid-19-pandemic-in-a-south-figure-1.jpg)


Verification
Claims the paper makes
12 Valid · 2 Not valid · 10 Not checked · 101 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“making it unclear whether observed patterns reflected true reductions in infectious disease burden, as reported in other settings41–45, or changes in death attributions associated with lockdown-related disruptions to MCCD functions.”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Results > Deaths attributed to specific causes during the pandemic period
What the sources say
- Supportedcites [41] Cowling, B. J. et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health 5, e279–e288 (2020). source
The citation is attached to the report of reduced infectious disease burden in another setting, not to the citing authors’ uncertainty about death attribution. The Findings report a substantial decline in influenza transmission in Hong Kong, and the Discussion says control measures coincided with that decline. The source does not address maternal deaths or MCCD functions. (LLM, conf=0.88)
- Supportedcites [42] Eden, J.-S. et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat. Commun. 13, 2884 (2022). source
The citation is attached to the report of reduced infectious disease burden in other settings, not to the citing authors’ uncertainty about death attribution or MCCD functions. The Results and discussion section reports a rapid decline in RSV incidence in Australian states after COVID-19 restrictions were introduced; no page number is available in our copy. (LLM, conf=0.88)
- Supportedcites [43] Burnett, E., Parashar, U. D., Winn, A. & Tate, J. E. Trends in rotavirus laboratory detections and internet search volume before and after rotavirus vaccine introduction and in the context of the coronavirus disease 2019 pandemic—United States, 2000–2021. J. Infect. Dis. 226, 967–974 (2022). source
The Discussion reports significantly less rotavirus activity during the pandemic and says that low test positivity and internet searches suggest a real reduction in rotavirus disease. This supports the cited example of a reduction in infectious disease burden in another setting. The alternative explanation involving maternal deaths and MCCD functions is not attributed to this source. (LLM, conf=0.88)
- Supportedcites [44] Kraay, A. N. M. et al. Impact of nonpharmaceutical interventions for severe acute respiratory syndrome coronavirus 2 on norovirus outbreaks: an analysis of outbreaks reported by 9 US states. J. Infect. Dis. 224, 9–13 (2021). source
The citation supports the clause about reductions in infectious disease burden reported in other settings, not the citing authors’ uncertainty about death attribution or MCCD functions. The Abstract reports a significant decline in norovirus outbreaks across nine US states and concludes that NPIs appear to have reduced incidence; the Discussion reports a decline of more than 80% compared with prior years. (LLM, conf=0.91)
- Supportedcites [45] Brueggemann, A. B. et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit. Health 3, e360–e370 (2021). source
The Introduction reports sharp declines in invasive disease caused by three respiratory bacteria across 26 countries and territories. The Discussion says the sustained reductions were unlikely to result from reduced hospital admissions. This supports the cited example of a real reduction in infectious disease burden; the uncertainty about death attribution and MCCD disruption is the citing authors’ own framing. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“attributions to senility and uncategorized causes pose particular risks of inaccuracy33,60.”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Discussion
What the sources say
- Supportedcites [33] Jha, P. et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLOS Med. 3, e18 (2005). source
The Introduction ('Alternative Designs for Measuring Mortality') states that 'Problems with inconsistent physician attribution of causes of death, especially for senility and ill-defined causes have been noted,' directly matching the claim's point about senility and uncategorized causes. The paper reinforces this with its own design and validation material: Methods ('Estimated Sample Size and Distribution') restricts adult analyses to ages 25–69 because those deaths are 'much less likely to be misclassified than deaths occurring after age 70,' and the Limitations (Discussion) plus Abstract note that VA classifies ~90% of deaths before age 70 but 'in old age... the proportion of classifiable deaths is lower,' while Results ('Validation Studies of Mortality Outcomes') quantify the reduction in deaths attributed to unspecified/unknown causes. The introductory sentence credits references [6,7], but the paper adopts and relies on the point alongside its own evidence, so it is not merely reported from another work. (LLM, conf=0.85)
- Supportedcites [60] Aleksandrowicz, L. et al. Performance criteria for verbal autopsy-based systems to estimate national causes of death: development and application to the Indian Million Death Study. BMC Med. 12, 1–14 (2014). source
The Discussion (p. Discussion) states that 'VA generally produces a proportion of deaths that are coded as ill-defined or unspecified causes, particularly at older ages', and that a rising ill-defined rate 'suggest[ed] decreasing quality' — enough that the Indian government ceased an earlier rural-health-centre COD system; the Results ('Ill-defined deaths') report misclassification after age 70 of 62% falling to 18%, and the Methods make 'a low ill-defined proportion of deaths before old age' a performance criterion, with the Results ('Physician coding patterns') noting ill-defined conditions were among those most often requiring adjudication. Senility appears in our copy only in the Methods table on key MDS features, as an example of an implausible attribution caught by the coding application's age checks ('no cervical cancer in males, or senility before old age') — consistent with, though narrower than, the claim's senility element. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“this total greatly exceeds global average increases of 8% in 2020 and 18% in 20214.”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Discussion
What the sources say
- Supportedcites [4] Msemburi, W. et al. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature 613, 130–137 (2023). source
The 'Global, regional and income group summary' section (p. 3 of our copy) states the global P-scores directly: 'there were 7.97% (UI 6.96% to 9.03%) and 18.30% (UI 15.99% to 21.15%) increases in deaths globally in 2020 and 2021, respectively, compared to what we would have expected if the pandemic had not occurred.' These round to the 8% and 18% figures the citing sentence attributes, and they are the global average percentage increases (P-scores), matching the claim's characterization. The same section reports the 14.83 million global excess-dead total against which the citing authors make the comparison. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Non-pharmaceutical interventions may have played a role in reducing individuals’ risk of death due to these causes, consistent with findings in several high-income settings59.”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Discussion
What the sources say
- Partly supportedcites [59] Kung, S., Doppen, M., Black, M., Hills, T. & Kearns, N. Reduced mortality in New Zealand during the COVID-19 pandemic. Lancet 397, 25 (2021). sourceExperimental — accuracy not yet measured
Our copy of the Kung et al. Lancet correspondence supports only half of the attributed point. The discussion (p. 1) hedges that 'alternative factors, such as fewer deaths from road traffic accidents, occupational causes, air pollution, and postsurgical complications, might also have had a role in the reduction of all-cause mortality' — i.e. a speculative contribution of public health measures to injury-type deaths, not a demonstrated reduction in risk. Nothing in our copy mentions cirrhosis or liver disease; searches for 'cirrhosis liver disease deaths' returned only the all-cause mortality passages, and the paper explicitly states that interpretation is 'limited by an absence of data on specific causes of death, due to coding delays and coronial inquiries'. The claim's liver-disease component and its framing as a finding are therefore not attributable to this source. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“First, cause-of-death determinations in MCCD data are expected to be imperfect33,61.”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Discussion
What the sources say
- Supportedcites [33] Jha, P. et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLOS Med. 3, e18 (2005). source
The Introduction’s “Alternative Designs for Measuring Mortality” section identifies Medically Certified Causes of Death (MCCD) and notes inconsistent physician attribution of causes of death, especially for senility and ill-defined causes. This supports the claim that MCCD cause-of-death determinations can be imperfect; no page number is provided in our copy. (LLM, conf=0.92)
- Not checked yetcites [61] Mahapatra, P. & Chalapati Rao, P. V. Cause of death reporting systems in India: a performance analysis. Natl. Med. J. India 14, 154–162 (2001).
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
81 more claims · 2 with their cited sources checked
Create a free account to see all 125 claims and to verify the 19 references still open.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies with empirical data have also reported similar reductions during the pandemic”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Results > Deaths attributed to specific causes during the pandemic period
“50% (49–59%) fewer deaths attributed to infectious and maternal conditions”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Results > Deaths attributed to specific causes during the pandemic period
“| Total | 520 (427, 629) | 260 | −260 (−369, −167) | 0.50 (0.41, 0.61) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Results > Changes in all-cause mortality during the pandemic
“the period from 24 March to 31 May, 2020 saw 7% (0–3%) lower-than-expected all-cause mortality (Table 1).”
§ Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city > Abstract
“Implementation of lockdown measures was associated with a 7% (0–13%) reduction in all-cause mortality”
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Wang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., Aravkin, A. Y., Bisignano, C., Barber, R. M., Alam, T., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02796-3 · Cited by 2,069
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Cowling, B. J., Ali, S. T., Ng, T. W. Y., Tsang, T. K., Li, J. C. M., Fong, M. W., Liao, Q., Kwan, M. Y., Lee, S. L., Chiu, S. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30090-6 · Cited by 1,258
The WHO estimates of excess mortality associated with the COVID-19 pandemic
Msemburi, W., Karlinsky, A., Knutson, V., Aleshin-Guendel, S., Chatterji, S., & Wakefield, J. (2023) · Nature · doi:10.1038/s41586-022-05522-2 · Cited by 1,064
Scientific and ethical basis for social-distancing interventions against COVID-19
Lewnard, J. A., & Lo, N. C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30190-0 · Cited by 935
Self-citationKarlinsky, A., & Kobak, D. (2021) · eLife · doi:10.7554/elife.69336 · Cited by 772
Katsoularis, I., Fonseca-Rodríguez, O., Farrington, P., Lindmark, K., & Fors Connolly, A.-M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00896-5 · Cited by 582
Risks and burdens of incident diabetes in long COVID: a cohort study
Xie, Y., & Al-Aly, Z. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00044-4 · Cited by 564
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00077-7 · Cited by 546
Research works printed but not linked: 3
- Nielsen, K. Hungry nation: food, famine, and the making of modern India. J. South Asian Studies 42, 1–2 (2019).
- Seal, S. C. Epidemiological studies of plague in India. Bull. World Health Organ. 23, 283–292 (1960).
- Balsari, S., Buckee, C. & Leaning, J. Why every body counts. Available from: https://speakingofmedicine.plos.org/2022/08/16/why-every-body-counts/. (2023).
Cited by
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
Jin, W., Huang, K., Ding, Z., Zhang, M., Li, C., Yuan, Z., Ma, K., & Ye, X. (2025) · Biomarker Research · doi:10.1186/s40364-024-00718-2 · Cited by 74
Ledesma, J. R., Basting, A. V. L., Chu, H. T., Ma, J., Zhang, M., Vongpradith, A., Novotney, A., Dalos, J., Zheng, P., Murray, C. J. L., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11092191 · Cited by 16
What is the impact of the COVID-19 pandemic on tuberculosis?
Kyu, H. H., & Ledesma, J. R. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00360-1 · Cited by 13
Gibo, M., Kojima, S., Fujisawa, A., Kikuchi, T., & Fukushima, M. (2024) · Cureus · doi:10.7759/cureus.57860 · Cited by 12
Retracted
Metadata
- Authors
- Lewnard, J. A., B, C. M., Kang, G., & Laxminarayan, R.
- Affiliations
- University of California, Berkeley (US)
- Christian Medical College, Vellore (IN)
- Princeton University (US)
- Corresponding author
- Lewnard, Joseph A.
- Venue
- Nature Communications
- Published
- 2023-06-15
- Volume
- 14
- Issue
- 1
- Pages
- 3563-3563
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10272147
- OpenAlex
- W4380785151
- Semantic Scholar
- 79918b7172b42c74ccca25f21b70afaade659d4f
- Cited by
- 23
- References
- 69
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 4
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (MIDASNI2020-3)
- Bill and Melinda Gates Foundation (INV029062)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- excess mortality, COVID-19 pandemic, lockdown measures, all-cause mortality, cardiovascular mortality, cerebrovascular disease, diabetes mortality, cancer mortality, trauma mortality, maternal mortality, liver disease, Madurai, low- and middle-income countries
- MeSH terms
- COVID-19, Cause of Death, Communicable Disease Control, Humans, India, Mortality, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city. https://app.cochat.ai/papers/10.1038/s41467-023-39322-7
- The paper
- Lewnard, J. A., B, C. M., Kang, G., & Laxminarayan, R. (2023). Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city. Nature Communications. https://doi.org/10.1038/s41467-023-39322-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.